Panacea Life Sciences and Benivita Launch Benivita PLSH to Expand Virtual Health Benefits

Reuters
2025/11/18
<a href="https://laohu8.com/S/PLSH">Panacea Life</a> Sciences and Benivita Launch Benivita PLSH to Expand Virtual Health Benefits

Panacea Life Sciences Holdings Inc. has announced the launch of Benivita PLSH, a new joint venture with Benivita Inc., aimed at transforming access to non-insurance benefits, virtual telemedicine services, and wellness programs across the United States. Through this partnership, Panacea Life Sciences Holdings will own 100% of Benivita PLSH, providing initial operating capital and issuing restricted common shares to Benivita Inc. The platform will leverage PLSH's infrastructure, Benivita's expertise in direct and multi-level marketing, and New Benefits Inc.'s leadership in benefit aggregation. Benivita PLSH will offer individuals and families direct access to benefit networks typically reserved for corporate employees, with a focus on transparency, compliance, and affordability, particularly targeting underserved markets such as the U.S. Latino population.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Panacea Life Sciences Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA25471) on November 18, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10